Travatan Dosage/Direction for Use

Use in adults including the elderly population: 1 drop of TRAVATAN eye drops in the conjunctival sac of the affected eye(s) once daily. Optimal effect is obtained if the dose is administered in the evening.
Paediatric population: The efficacy and safety of TRAVATAN eye drops in patients below the age of 18 years have not been established and its use is not recommended in these patients until further data become available.
Hepatic and renal impairment: TRAVATAN eye drops has been studied in patients with mild to severe hepatic impairment and in patients with mild to severe renal impairment (creatinine clearance as low as 14 ml/min). No dosage adjustment is necessary in these patients.
Method of Administration: TRAVATAN eye drop is for ocular use.
Nasolacrimal occlusion or gently closing the eyelid after administration is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic adverse reactions.
If a dose is missed, treatment should be continued with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily.
When substituting another ophthalmic anti-glaucoma agent with TRAVATAN eye drops, the other agent should be discontinued and TRAVATAN eye drops should be started the following day.
If more than 1 topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart.
The patient should remove the protective overwrap immediately prior to initial use.
To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids surrounding areas or other surfaces with the dropper tip of the bottle.